This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Winners & Losers: ImClone

Barr's shares traded up 68 cents, or 1%, to $65.98.

In other regulatory news, shares of Cadence (CADX) climbed $3.87, or 60.3%, to $10.29 after the company said the Food and Drug Administration will not require any additional trials for its new-drug application (NDA) for Acetavance, an intravenous formulation of acetaminophen. Pending the completion of three ongoing trials, it anticipates filing the NDA in the second quarter of 2009 for approval to treat acute pain and fever in adults and children.

And, of course, earnings. British drugmaker AstraZeneca (AZN - Get Report) reported net profit of $1.62 billion in the recent quarter, up from $1.43 billion a year prior, on revenue that rose 9% to $7.96 billion. The company upped its 2008 core earnings per share guidance by 15 cents to a range of $4.60 to $4.90. Shares rose 3.8% to $48.55.

On the falling side, medical technology company Hologic (HOLX - Get Report) missed adjusted profit estimates by 4 cents a share and reined in full-year guidance. Jefferies analyst Arthur Henderson downgraded the stock to hold from buy and cut his price target to $24 from $28. Shares were down $4.38, or 19.2%, at $18.47.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
CADX $0.00 0.00%
ONXX $0.00 0.00%
IMCL $5.50 10.00%
AZN $67.36 0.03%
GSK $46.02 0.92%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs